Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials
The data reported to Japan’s health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether…
Author
AstraZeneca-Merck’s Lynparza gets US FDA nod for prostate cancer treatment
The drug approval by the US regulator is for treating patients with a form of prostate cancer that could not be held back by…
Teva Pharm gets approval in China for Huntington’s treatment
Austedo, the drug, was included in China’s fast-tracked approval channel as a rare disease treatment of “significant clinical…
GSK’s long-acting injection beats Truvada in HIV prevention trial
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection
Thermo Fisher launches 39 euros/share bid for Qiagen
Thermo Fisher said in a statement that the period for acceptance of the offer was scheduled to end on July 27 at 2200 GMT
Remdesivir close to EU’s initial authorisation as COVID-19 treatment
The European Medicines Agency (EMA) has already recommended the compassionate use of remdesivir, which allows a drug to be…
UK to invest up to 93 million pounds in new coronavirus vaccine centre
The funding will ensure the new centre opens in Summer 2021, a year ahead of schedule, the department said
Novartis CEO says any new coronavirus vaccine will take two years
Moderna has sped up plans for its experimental COVID-19 vaccine and said it expected to start a late-stage trial in early summer
Health groups ask India to rescind Gilead’s patents for COVID-19 drug remdesivir
Gilead’s three patents in India for remdesivir stem from 2009 when the drug was in development to treat Ebola
Coronavirus vaccine possible in about a year, says EU agency
"For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so…